Clinical Trial Update: A 5 Treatment Period Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR) [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 pharmacokinetic study of the diazoxide choline controlled-release tablet (DCCR) in Prader-Willi Syndrome, focusing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prader-willi Syndrome

Drugs mentioned

• DCCR (diazoxide choline)

Snippet

Sponsor: Essentialis, Inc. | Conditions: Prader-Willi Syndrome | Phase 2 | Status: UNKNOWN